News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
119 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18828)
Month
January (4345)
February (4356)
March (4475)
April (4721)
May (4999)
June (4103)
July (3643)
August (3329)
September (4039)
October (5055)
November (4470)
December (3799)
Day
1 (309)
2 (217)
3 (119)
4 (10)
5 (15)
6 (240)
7 (330)
8 (243)
9 (293)
10 (101)
11 (2)
12 (13)
13 (228)
14 (250)
15 (299)
16 (255)
17 (104)
18 (5)
19 (7)
20 (208)
21 (277)
22 (218)
23 (219)
24 (80)
25 (4)
26 (9)
27 (24)
28 (229)
29 (306)
30 (261)
31 (124)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
Allergan Declares Second Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share
Allergan plc announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the second quarter of 2019.
May 3, 2019
·
3 min read
Business
Paradigm Announces Foundation Dedicated to Community Service
Paradigm announces the formation of the Paradigm Foundation, a charitable initiative dedicated to serving Dane County and the surrounding region.
May 3, 2019
·
2 min read
Business
Wills Eye Hospital Physicians Named “Top Docs” in 2019 Philadelphia Magazine List
Wills Eye Hospital Physicians are once again named to Philadelphia Magazine’s Annual “Top Docs” list from a vote by their peers throughout the region.
May 3, 2019
·
2 min read
Lumenis Announces New Clinical Evidence for BPH Using its Patent-Protected MOSES™ Technology
Meaningful advantages of MOSES for BPH procedures and the continuous flow of clinical evidence for its use in lithotripsy
May 3, 2019
·
5 min read
Biotech Beach
MDxHealth Announces Presentation of Positive Data for ConfirmMDx and SelectMDx in Prostate Cancer Diagnosis
Data that further supports clinical adoption and efficacy of ConfirmMDx and SelectMDx to be presented at the American Urological Association Annual Meeting
May 3, 2019
·
4 min read
Pharm Country
Smile Train Celebrates 20 Years of Impact and More than One Million Lives Changed
The World’s Largest Cleft Charity Hosts Star-Studded 20th Anniversary Gala, with Alexa Ray Joel, Kelly Rutherford, Dikembe Mutombo, Rev Run, Kenyan Drake, Kristen Taekman and many others
May 3, 2019
·
4 min read
BioCapital
AUA and SUFU Release New Clinical Guideline on Urinary Incontinence after Prostate Treatment
The American Urological Association, a leading global urology association, and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, released a new clinical guideline on the treatment of urinary incontinence after prostate treatment.
May 3, 2019
·
2 min read
Business
DarioHealth Announces New Partnership With the American Diabetes Association
DarioHealth’s mission is to support people with diabetes and other chronic conditions in the U.S. and around the world.
May 3, 2019
·
6 min read
Genetown
Pear Therapeutics Initiates Feasibility Study to Treat Depressive Symptoms in People With Multiple Sclerosis
Novel Prescription Digital Therapeutic Will Be Evaluated for Feasibility and Usability Iterative Design Process Incorporates Extensive Patient and Clinician Feedback
May 3, 2019
·
3 min read
Teva to Present New Long-Term Data on Efficacy and Safety of Fremanezumab at 2019 American Academy of Neurology Annual Meeting
Findings describe the efficacy and safety results of clinical trials of fremanezumab through 12 months of treatment in patients with chronic and episodic migraine
May 3, 2019
·
11 min read
Previous
3 of 12
Next